{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:03:41Z","timestamp":1773288221648,"version":"3.50.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.beha.2011.02.003","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T21:33:05Z","timestamp":1302816785000},"page":"95-109","source":"Crossref","is-referenced-by-count":32,"title":["Pathology, pathogenesis and molecular genetics of follicular NHL"],"prefix":"10.1016","volume":"24","author":[{"given":"E.","family":"Leich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.beha.2011.02.003_bib1","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1200\/JCO.2006.06.4618","article-title":"Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study","volume":"25","author":"Herold","year":"2007","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.beha.2011.02.003_bib2","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","article-title":"Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group","volume":"106","author":"Hiddemann","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.003_bib3","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","year":"2008"},{"issue":"6","key":"10.1016\/j.beha.2011.02.003_bib4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-3083.2003.01264.x","article-title":"Follicular lymphoma cell lines, an in vitro model for antigenic selection and cytokine-mediated growth regulation of germinal centre B cells","volume":"57","author":"Eray","year":"2003","journal-title":"Scandinavian Journal of Immunology"},{"issue":"1","key":"10.1016\/j.beha.2011.02.003_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.leu.2404426","article-title":"Molecular pathways in follicular lymphoma","volume":"21","author":"Bende","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2011.02.003_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0b013e318166f46a","article-title":"Expression of the interferon regulatory factor 8\/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker","author":"Martinez","year":"2008","journal-title":"The American Journal of Surgical Pathology"},{"issue":"3","key":"10.1016\/j.beha.2011.02.003_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/path.1689","article-title":"Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation","volume":"205","author":"Schraders","year":"2005","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.beha.2011.02.003_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.immunol.18.1.495","article-title":"The RAG proteins and V(D)J recombination: complexes, ends, and transposition","volume":"18","author":"Fugmann","year":"2000","journal-title":"Annual Review of Immunology"},{"issue":"12","key":"10.1016\/j.beha.2011.02.003_bib9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nri953","article-title":"Lymphoid malignancies: the dark side of B-cell differentiation","volume":"2","author":"Shaffer","year":"2002","journal-title":"Nature Reviews"},{"issue":"3","key":"10.1016\/j.beha.2011.02.003_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9440(10)64905-X","article-title":"High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection","volume":"160","author":"Albinger-Hegyi","year":"2002","journal-title":"The American Journal of Pathology"},{"issue":"5","key":"10.1016\/j.beha.2011.02.003_bib11","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2011.02.003_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cyto.a.20819","article-title":"BH3-only proteins: the death-puppeteer\u2019s wires","volume":"77","author":"Ghiotto","year":"2010","journal-title":"Cytometry A"},{"issue":"8","key":"10.1016\/j.beha.2011.02.003_bib13","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.cdd.4401987","article-title":"BCL2 family in DNA damage and cell cycle control","volume":"13","author":"Zinkel","year":"2006","journal-title":"Cell Death and Differentiation"},{"issue":"15","key":"10.1016\/j.beha.2011.02.003_bib14","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","article-title":"Aggressive lymphomas","volume":"362","author":"Lenz","year":"2010","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.beha.2011.02.003_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ng.2007.35","article-title":"AID is required for germinal center-derived lymphomagenesis","volume":"40","author":"Pasqualucci","year":"2008","journal-title":"Nature Genetics"},{"issue":"4","key":"10.1016\/j.beha.2011.02.003_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/gcc.1103","article-title":"Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)","volume":"30","author":"Horsman","year":"2001","journal-title":"Genes, Chromosomes & Cancer"},{"issue":"3","key":"10.1016\/j.beha.2011.02.003_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1044-579X(03)00014-2","article-title":"Cytogenetic evolution of follicular lymphoma","volume":"13","author":"Viardot","year":"2003","journal-title":"Seminars in Cancer Biology"},{"issue":"8","key":"10.1016\/j.beha.2011.02.003_bib18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/gcc.20780","article-title":"High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes","volume":"49","author":"Cheung","year":"2010","journal-title":"Genes, Chromosomes & Cancer"},{"issue":"16","key":"10.1016\/j.beha.2011.02.003_bib19","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-07-0456","article-title":"Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis","volume":"13","author":"Ross","year":"2007","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1016\/j.beha.2011.02.003_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/gcc.10314","article-title":"Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas","volume":"39","author":"Hoglund","year":"2004","journal-title":"Genes, Chromosomes & Cancer"},{"issue":"5","key":"10.1016\/j.beha.2011.02.003_bib21","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1182\/blood.V94.5.1773","article-title":"Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and T-cell lymphomas","volume":"94","author":"Baur","year":"1999","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2011.02.003_bib22","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1182\/blood-2001-11-0026","article-title":"Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype","volume":"100","author":"Li","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2011.02.003_bib23","first-page":"154","article-title":"Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia","volume":"89","author":"Rossi","year":"2004","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.beha.2011.02.003_bib24","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/leu.2009.114","article-title":"Array-based DNA methylation profiling in follicular lymphoma","volume":"23","author":"O\u2019Riain","year":"2009","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.beha.2011.02.003_bib25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1158\/0008-5472.CAN-08-2984","article-title":"Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome","volume":"69","author":"Killian","year":"2009","journal-title":"Cancer Research"},{"issue":"9","key":"10.1016\/j.beha.2011.02.003_bib26","doi-asserted-by":"crossref","first-page":"e6986","DOI":"10.1371\/journal.pone.0006986","article-title":"A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms","volume":"4","author":"Martin-Subero","year":"2009","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.beha.2011.02.003_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cell.2006.02.043","article-title":"Control of developmental regulators by polycomb in human embryonic stem cells","volume":"125","author":"Lee","year":"2006","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.beha.2011.02.003_bib28","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/eji.200424985","article-title":"Distinct expression patterns of polycomb oncoproteins and their binding partners during the germinal center reaction","volume":"34","author":"van Galen","year":"2004","journal-title":"European Journal of Immunology"},{"issue":"2","key":"10.1016\/j.beha.2011.02.003_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nature Genetics"},{"issue":"5A","key":"10.1016\/j.beha.2011.02.003_bib30","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1582-4934.2008.00399.x","article-title":"MicroRNA expression in lymphoid malignancies: new hope for diagnosis and therapy?","volume":"12","author":"Lawrie","year":"2008","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"5","key":"10.1016\/j.beha.2011.02.003_bib31","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","article-title":"MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas","volume":"142","author":"Roehle","year":"2008","journal-title":"British Journal of Haematology"},{"issue":"7","key":"10.1016\/j.beha.2011.02.003_bib32","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1582-4934.2008.00628.x","article-title":"Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma","volume":"13","author":"Lawrie","year":"2009","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.beha.2011.02.003_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.immunol.16.1.395","article-title":"BCL-2 family: regulators of cell death","volume":"16","author":"Chao","year":"1998","journal-title":"Annual Review of Immunology"},{"issue":"5","key":"10.1016\/j.beha.2011.02.003_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000055123","article-title":"Apoptosis and its relevance in cancer therapy","volume":"24","author":"Ehlert","year":"2001","journal-title":"Onkologie"},{"issue":"3","key":"10.1016\/j.beha.2011.02.003_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2141.2008.07353.x","article-title":"Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma","volume":"143","author":"Pro","year":"2008","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1016\/j.beha.2011.02.003_bib36","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-08-0144","article-title":"Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy","volume":"15","author":"Kang","year":"2009","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.beha.2011.02.003_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0092-8674(89)90174-8","article-title":"bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation","volume":"57","author":"McDonnell","year":"1989","journal-title":"Cell"},{"issue":"6306","key":"10.1016\/j.beha.2011.02.003_bib38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/349254a0","article-title":"Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)","volume":"349","author":"McDonnell","year":"1991","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.beha.2011.02.003_bib39","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1084\/jem.20061292","article-title":"Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis","volume":"203","author":"Roulland","year":"2006","journal-title":"The Journal of Experimental Medicine"},{"issue":"7","key":"10.1016\/j.beha.2011.02.003_bib40","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1084\/jem.20082842","article-title":"Agricultural pesticide exposure and the molecular connection to lymphomagenesis","volume":"206","author":"Agopian","year":"2009","journal-title":"The Journal of Experimental Medicine"},{"issue":"3","key":"10.1016\/j.beha.2011.02.003_bib41","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2141.2003.04086.x","article-title":"Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes","volume":"120","author":"Horsman","year":"2003","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.beha.2011.02.003_bib42","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2009-01-198580","article-title":"Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations","author":"Leich","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2011.02.003_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9440(10)63313-5","article-title":"Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component","volume":"165","author":"Katzenberger","year":"2004","journal-title":"The American Journal of Pathology"},{"issue":"10","key":"10.1016\/j.beha.2011.02.003_bib44","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1182\/blood.V99.10.3806","article-title":"Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3","volume":"99","author":"Ott","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2011.02.003_bib45","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1626::AID-CNCR27>3.0.CO;2-0","article-title":"Primary follicular lymphoma of the testis in childhood","volume":"85","author":"Finn","year":"1999","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.beha.2011.02.003_bib46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2559.2006.02501.x","article-title":"BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma","volume":"49","author":"Goodlad","year":"2006","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.beha.2011.02.003_bib47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1440-1827.2006.02072.x","article-title":"Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and\/or Bcl6 or p53 expression","volume":"57","author":"Guo","year":"2007","journal-title":"Pathology International"},{"issue":"11","key":"10.1016\/j.beha.2011.02.003_bib48","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/sj.leu.2402707","article-title":"Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics","volume":"16","author":"Jardin","year":"2002","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.beha.2011.02.003_bib49","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1038\/sj.leu.2404817","article-title":"Trisomy 3 is a specific genomic aberration of t(14;18) negative follicular lymphoma","volume":"21","author":"Tagawa","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.beha.2011.02.003_bib50","first-page":"235","article-title":"Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Laboratory investigation","volume":"84","author":"Zha","year":"2004","journal-title":"A Journal of Technical Methods and Pathology"},{"issue":"12","key":"10.1016\/j.beha.2011.02.003_bib51","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.13239","article-title":"Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression","volume":"93","author":"Gagyi","year":"2008","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.beha.2011.02.003_bib52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00432-006-0188-3","article-title":"Non-Hodgkin lymphoma with t(14;18): clonal evolution patterns and cytogenetic-pathologic-clinical correlations","volume":"133","author":"Aamot","year":"2007","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.1016\/j.beha.2011.02.003_bib53","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2008-05-154013","article-title":"The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and a poorer overall survival","author":"O\u2019Shea","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2011.02.003_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood-2008-02-140616","article-title":"Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances","volume":"113","author":"Cheung","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2011.02.003_bib55","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1182\/blood-2008-08-174953","article-title":"Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation","volume":"113","author":"O\u2019Shea","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2011.02.003_bib56","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2002-08-2482","article-title":"BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma","volume":"102","author":"Akasaka","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2011.02.003_bib57","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2002-07-2119","article-title":"Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations","volume":"101","author":"Martinez-Climent","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.003_bib58","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-03-272278","article-title":"Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones","author":"Eide","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2011.02.003_bib59","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/gcc.20606","article-title":"Prognostic significance of secondary cytogenetic alterations in follicular lymphomas","volume":"47","author":"Johnson","year":"2008","journal-title":"Genes, Chromosomes & Cancer"},{"issue":"21","key":"10.1016\/j.beha.2011.02.003_bib60","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"10.1016\/j.beha.2011.02.003_bib61","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2011.02.003_bib62","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1158\/1078-0432.CCR-09-2487","article-title":"A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1\u2013positive, regulatory, cytotoxic, and helper T cells and macrophages","volume":"16","author":"Wahlin","year":"2010","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.beha.2011.02.003_bib63","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2004-06-2298","article-title":"Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment","volume":"105","author":"Glas","year":"2005","journal-title":"Blood"},{"issue":"31","key":"10.1016\/j.beha.2011.02.003_bib64","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2006.06.4642","article-title":"Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome","volume":"24","author":"Lee","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1016\/j.beha.2011.02.003_bib65","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","volume":"106","author":"Farinha","year":"2005","journal-title":"Blood"},{"issue":"2 Pt 1","key":"10.1016\/j.beha.2011.02.003_bib66","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/1078-0432.CCR-06-1734","article-title":"CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma","volume":"13","author":"Wahlin","year":"2007","journal-title":"Clinical Cancer Research"},{"issue":"9","key":"10.1016\/j.beha.2011.02.003_bib67","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1182\/blood-2007-10-115915","article-title":"Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling","volume":"111","author":"Byers","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2011.02.003_bib68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1309\/AJCP1TA3FLOQTMHF","article-title":"C-C chemokine receptor 1 expression in human hematolymphoid neoplasia","volume":"133","author":"Anderson","year":"2006","journal-title":"American Journal of Clinical Pathology"},{"issue":"24","key":"10.1016\/j.beha.2011.02.003_bib69","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1182\/blood-2009-11-253260","article-title":"Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment","volume":"115","author":"Clear","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.003_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2010.06.014","article-title":"Prognostic impact of CD31-positive microvessel density in follicular lymphoma patients treated with immunochemotherapy","author":"Taskinen","year":"2010","journal-title":"European Journal of Cancer"},{"issue":"6","key":"10.1016\/j.beha.2011.02.003_bib71","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2141.2005.05954.x","article-title":"Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma","volume":"132","author":"Michels","year":"2006","journal-title":"British Journal of Haematology"},{"issue":"2","key":"10.1016\/j.beha.2011.02.003_bib72","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1182\/blood-2003-06-1901","article-title":"Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma","volume":"103","author":"Zhao","year":"2004","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.beha.2011.02.003_bib73","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1158\/1078-0432.CCR-05-0637","article-title":"Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma","volume":"11","author":"Gulmann","year":"2005","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1016\/j.beha.2011.02.003_bib74","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/path.1986","article-title":"Prognostic significance of PU.1 in follicular lymphoma","volume":"209","author":"Torlakovic","year":"2006","journal-title":"The Journal of Pathology"},{"issue":"7","key":"10.1016\/j.beha.2011.02.003_bib75","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2004-07-2721","article-title":"High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma","volume":"105","author":"Bjorck","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.beha.2011.02.003_bib76","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood-2006-09-046391","article-title":"Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling","volume":"109","author":"Sakhinia","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2011.02.003_bib77","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3324\/haematol.13574","article-title":"Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols","volume":"94","author":"de Jong","year":"2009","journal-title":"Haematologica"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692611000107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692611000107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T04:42:56Z","timestamp":1712378576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692611000107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1521692611000107"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2011.02.003","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}